Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species ...

The signature seems consistent across CRPS populations irrespective of diet, geography, and other factors, and it persists ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...